Gsk plc

Plus: Updates from Enara, Paq, Priothera, Eccogene

New HHS vaccine policy could make it impossible to launch improved versions of vaccines

GSK’s Jemperli leads to sustained clinical complete responses in 95% of rectal cancer patients

German pharma adds drugs for rare tumors, expands U.S. footprint via $3.9B acquisition

Faster recruitment is the biggest factor, but it’s not the only driver of China’s new edge

Shanghai biotech’s shares double in debut

Uncertainty in markets may be quashing appetite to complete transactions

HHS Secretary Kennedy inaccurately said single-antigen vaccines don’t protect against respiratory diseases

First drug for Prader-Willi hyperphagia, first Xolair biosimilar

At least 30 companies have bispecific antibodies in development for autoimmune and inflammatory diseases